Effector and memory CTL differentiation

722Citations
Citations of this article
672Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Technological advances in recent years have allowed for an everexpanding ability to analyze and quantify in vivo immune responses. MHC tetramers, intracellular cytokine staining, an increasing repertoire of transgenic and "knockout" mice, and the detailed characterization of a variety of infectious models have all facilitated more precise and definitive analyses of the generation and function of cytotoxic T lymphocytes (CTL). Understanding the mechanisms behind the differentiation of effector and memory CTL is of increasing importance to develop vaccination strategies against a variety of established and emerging infectious diseases. This review focuses on recent advances in our understanding of how effector and memory CTL differentiate and survive in vivo in response to viral or bacterial infection. Copyright © 2007 by Annual Reviews. All rights reserved.

Cite

CITATION STYLE

APA

Williams, M. A., & Bevan, M. J. (2007). Effector and memory CTL differentiation. Annual Review of Immunology. https://doi.org/10.1146/annurev.immunol.25.022106.141548

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free